BeStock  
Stocks › Biotechnology › RAPP

Rapport Therapeutics RAPP

US equityMarket cap rank #2939Biotechnology
$23.16 −$0.43 (-1.82%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $23.16 0.00%
Open$23.23
Prev close$23.59
Day range$23.00 – $23.83
Volume437.7K
Market cap$1.37B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RAPP at a glance

Shares of Rapport Therapeutics are down 1.82% at $23.16. The company is worth $1.37B, number 2939 out of 3753 on our list.

It is close to the bottom of its 52-week range ($22.06 to $52.93), 56.2% under the high. Holders are behind 15.0% over twelve months, and down 53.1% across the last three months.

On the chart it has slipped under both the 50-day ($29.85) and 200-day ($35.51) moving averages; RSI is 37, and the last 30 sessions moved at roughly 100% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $40.24M.

14 analysts follow the stock and the average call is "buy". The mean target, $68.00, sits 193.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$22.50 / $25.00
Average price today$23.30
Volume437.7KAvg (90d) 644.3K
Turnover$10.20M
Turnover rate1.08%of shares outstanding
Volume ratio0.94vs. recent average pace
Day amplitude3.52%
Market cap$1.37B
Float market cap$941.89M
Shares outstanding40.67M
EPS (TTM)-$2.86
P/B3.51
Book value / share$6.60
Net profit (TTM)-$169.54M
Net assets$391.19M
30-day volatility99.9%annualized
Avg daily range (ATR)6.41%of price, 14 days
Max drawdown (1y)-57.1%-55.9% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

14 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 36.0 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability6.6
Momentum8.9
Financial health99.1
Analyst view96.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$68.00+193.6% vs. current price
Consensus ratingBuy14 analysts covering
Morningstar fair value$44.28Price is below fair value

Wall Street’s average 12-month target is $68.00, 193.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $44.28, so shares trade 47.7% below that estimate. On earnings multiple, it sits in the 73rd percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.8%
1 week
-11.4%
1 month
-12.7%
3 months
-53.1%
6 months
-38.6%
Year to date
-23.7%
1 year
-15.0%
Day range
$23.00$23.83
52-week range
$22.06$52.93

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-7.2%Bearish
Price vs 50-day average-22.4%Bearish
Price vs 200-day average-34.8%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)37.2Bearish
MACD (12,26,9)-1.66Bullish
Bollinger band position17%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RAPP ranks on BeStock

Market value#2927 of 3734
Closeness to 52-week high#3216 of 3724
Dollar volume today#2385 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RAPP is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RAPP.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RAPP

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RAPP stock: common questions

What is RAPP's latest share price?

$23.16 is the latest print for RAPP, a move of -1.82% against yesterday's close of $23.59. Today's low and high so far: $23.00 and $23.83.

What is RAPP worth in total?

Equity value comes to $1.37B at the current price. By that measure it is number 2939 of the 3753 names in our coverage.

Is RAPP near its 52-week high or low?

The year's floor is $22.06 and the ceiling $52.93. Shares are 56.2% away from that ceiling.

Does Rapport Therapeutics pay a dividend?

Our data shows no dividend paid by Rapport Therapeutics over the trailing twelve months.

Is RAPP rated a buy by Wall Street?

Of 14 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $68.00, with the most cautious at $47.00 and the most optimistic at $91.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RAPP.

Sign in to join the discussion.

Scroll to Top